Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
365.10    -2.30 (-0.63%)
Bid:
366.50
Ask:
366.80
Spread: 0.30 (0.082%)
Market Cap: £7.50b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

Director/PDMR Shareholding

9 Dec 2022 15:27

RNS Number : 2713J
Marks and Spencer Group PLC
09 December 2022
 

Director/PDMR Shareholding

 

Marks and Spencer Group plc (the 'Company') announces that on 9 December 2022 it was notified of the following transactions in the Company's Ordinary 1p shares undertaken by directors / persons discharging managerial responsibility ('PDMRs'):

 

1. Performance Share Plan Award 2022/23

The Performance Share Plan ('PSP') continues to be the Company's primary long-term incentive plan for executives. As a result, an award of 859,537 shares under the PSP was made on 9 December 2022 to an incoming PDMR of the Company, Alex Freudmann, Managing Director, Food.

 

As with the awards granted on 5 July 2022 to our other PDMRs, this award has been granted as conditional shares, the vesting of which is subject to the continued employment of the participant and satisfaction of certain performance conditions, as disclosed in the Company's 2022 Annual Report published on 7 June 2022. Specifically, the vesting of the award will depend on relative Total Shareholder Return (TSR), the Company's Earnings Per Share (EPS), Return on Capital Employed (ROCE) and strategic measures over a fixed three-year performance period starting on the first day of the financial year in which the award was granted.

 

On vesting, the award is subject to an additional, mandatory two-year holding period, making a total period of five years post grant. The value of dividends accrued, in the form of dividend equivalents, will be paid at the end of the period (third anniversary) based on the number of vested shares. No consideration was paid for the grant of the award. For the purposes of this award, a share price of £1.3961 was used, being the five-day average share price immediately preceding the July grant date of 5 July 2022.

 

2. Restricted Share Plan Award

Alex Freudmann has also been granted an award of conditional shares under the Company's Restricted Share Plan ('RSP'). This award compensates, on a fair value basis, the share awards forfeited on resigning from his role with Endeavour Group. The fair value has been calculated to take account of the original performance period and the estimated satisfaction of the performance conditions of the original awards. The original vesting timeline for the first tranche of this award has been extended by eight months. The vesting of the final tranche of the award has been aligned to the Company's 2021 PSP awards and is subject to satisfaction of the same performance conditions, as disclosed in the Company's 2021 Annual Report published on 2 June 2021.

 

The value of dividends accrued, in the form of dividend equivalents, will be paid on the vesting date based on the number of vested shares. No consideration was paid for the grant of the award and no price is payable on the exercise of the award. The Company requires Alex Freudmann to have an equity position equivalent to 100% of salary within 5 years of appointment. For the purposes of this award, the five-day average share price immediately preceding the date of grant of £1.2227 was used for the first tranche. For the final tranche of the award, a share price of £1.5267 was used, being the five-day average share price immediately preceding the 2021 PSP grant date of 29 June 2021.

 

Conditional RSP shares granted

Vesting Date

397,480

25 March 2024

655,007

28 June 2024

 

3. Restricted Share Plan Vesting

Vesting of an award granted on 6 July 2020 to Stuart Machin under the Company's Restricted Share Plan ('RSP'), and subsequent sale of shares to satisfy the tax and National Insurance liabilities arising as set out below.

 

The award, as previously announced on 6 July 2020, was a conditional share award of 100,000 shares vesting in two tranches over three years, subject to Stuart's continued employment with the Company. This vesting is the first of the two tranches. Following his appointment in May 2022 as CEO, the Company requires Stuart Machin to have an equity position equivalent to 250% of salary within 5 years of appointment.

 

PDMR

 

 

Shares vested on 9 December 2022

Shares sold to cover tax and NI

Shares retained by individual

S Machin

50,000

23,801

26,199

 

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulations.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

A Freudmann

2

Reason for the notification

a)

Position/status

PDMR (Managing Director, Food)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 1p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Award of conditional shares pursuant to the Marks and Spencer Group Performance Share Plan

2. Award of conditional shares pursuant to the Marks and Spencer Group Restricted Share Plan

c)

Price(s) and volume(s)

1. PSP

Price(s)

Volume(s)

Nil-cost

859,537

2. RSP

Price(s)

Volume(s)

Nil-cost

1,052,487

d)

Aggregated information

-

Aggregated volume

-

Price

1. PSP

Price(s)

Volume(s)

Total

Nil-cost

859,537

 £0.00

2. RSP

Price(s)

Volume(s)

Total

Nil-cost

1,052,487

 £0.00

e)

Date of the transaction

2022-12-09

f)

Place of the transaction

Grant of conditional shares occurred outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

S Machin

2

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 1p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

3. Vesting of 50,000 shares awarded under the Restricted Share Plan.

4. Subsequent sale of 23,801 shares acquired under the RSP award to cover the tax and NI liability, with 26,199 shares retained.

c)

Price(s) and volume(s)

3. Vesting

Price(s)

Volume(s)

£0.01

50,000

4. Sale

Price(s)

Volume(s)

£1.226729

23,801

d)

Aggregated information

-

Aggregated volume

-

Price

3. Vesting

Price(s)

Volume(s)

Total

£0.01

50,000

 £500.00

4. Sale

Price(s)

Volume(s)

Total

£1.226729

23,801

 £29,197.38

e)

Date of the transaction

2022-12-09

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUBDDXDGDGDC
Date   Source Headline
1st Jun 202610:00 amRNSAnnual Financial Report
1st Jun 20269:00 amRNSIssue of Shares and Total Voting Rights
28th May 20264:23 pmRNSLichfield Fulfilment Centre Disposal Completion
28th May 20262:12 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSDirector/PDMR Shareholding
20th May 202610:30 amRNSDirectorate change
20th May 20267:00 amRNSFinal Results
1st May 20269:00 amRNSIssue of Shares and Total Voting Rights
28th Apr 20262:57 pmRNSDirector/PDMR Shareholding
28th Apr 202610:40 amRNSHolding(s) in Company
1st Apr 20269:00 amRNSIssue of Shares and Total Voting Rights
30th Mar 20262:07 pmRNSDirector/PDMR Shareholding
24th Mar 202610:35 amRNSDirector/PDMR Shareholding
2nd Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20261:00 pmRNSIssue of Shares and Total Voting Rights
19th Feb 20269:38 amRNSHolding(s) in Company
17th Feb 20263:23 pmRNSDirector/PDMR Shareholding
5th Feb 202611:48 amRNSDirector Declaration
3rd Feb 20269:57 amRNSDirector/PDMR Shareholding
2nd Feb 20269:00 amRNSTotal Voting Rights
29th Jan 202610:18 amRNSHolding(s) in Company
28th Jan 202610:42 amRNSDirector/PDMR Shareholding
12th Jan 20264:38 pmRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSChristmas Trading Results
2nd Jan 20269:00 amRNSBlock listing Interim Review
2nd Jan 20269:00 amRNSTotal Voting Rights
30th Dec 202512:40 pmRNSDirector/PDMR Shareholding
30th Dec 202512:40 pmRNSDirector/PDMR Shareholding
11th Dec 202510:00 amRNS2025 PSP Award Targets
10th Dec 202510:39 amRNSDirector/PDMR Shareholding
3rd Dec 20254:19 pmRNSDirector/PDMR Shareholding
3rd Dec 20251:43 pmRNSDirector/PDMR Shareholding
1st Dec 20255:34 pmRNSDirector/PDMR Shareholding
1st Dec 20259:00 amRNSTotal Voting Rights
28th Nov 202512:55 pmRNSDirector/PDMR Shareholding
17th Nov 20259:00 amRNSDirectorate change
12th Nov 20255:11 pmRNSDirector/PDMR Shareholding
12th Nov 20259:00 amRNSDirectorate change
11th Nov 202512:00 pmRNSInvestor Presentation
5th Nov 20257:00 amRNSHalf-year Financial Report
3rd Nov 20259:00 amRNSTotal Voting Rights
30th Oct 202510:00 amRNSDirectorate Change
28th Oct 20254:56 pmRNSDirector/PDMR Shareholding
14th Oct 202510:00 amRNSMarks and Spencer Chairmanship
1st Oct 20259:00 amRNSTotal Voting Rights
30th Sep 202511:36 amRNSDirector/PDMR Shareholding
1st Sep 20259:00 amRNSTotal Voting Rights
28th Aug 20252:23 pmRNSDirector/PDMR Shareholding
20th Aug 20259:30 amRNSDirectorate Change
1st Aug 20259:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.